{"entity":{"type":"insider","cik":"0001413041","url":"/insider/0001413041","json_url":"/insider/0001413041.json","name":"Platinum Long Term Growth VII, LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":2,"n_filings":1,"first":"2013-12-12","last":"2013-12-12","span_basis":"filed_date"},"name_variants":[{"name":"Platinum Long Term Growth VII, LLC","source":"filing","n_filings":1,"first_seen":"2013-12-12","last_seen":"2013-12-12"}],"transactions":[{"id":4530454,"accession":"0001140361-13-045902","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-13-045902","line_url":"/filing/0001140361-13-045902#line-2","is_derivative":false,"issuer_cik":"0001031927","issuer_name":"Echo Therapeutics, Inc.","issuer_ticker":"ECTE","issuer_name_source":null,"issuer_url":"/issuer/0001031927","owner_cik":null,"owner_name":"Platinum Liquid Opportunity Management (NY) LLC; Platinum Management (NY) LLC; Platinum Partners Liquid Opportunity Master Fund L.P.; Platinum Partners Value Arbitrage Fund, LP; Platinum Long Term Growth VII, LLC; LANDESMAN URI; Nordlicht Mark; Platinum-Montaur Life Sciences, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":55655.0,"shares_display":"55,655","price_per_share":2.75,"price_display":"2.75","price_state":"stated","total_value":153051.25,"total_display":"153,051.25","shares_owned_after":507824.0,"shares_owned_after_display":"507,824","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-12-10","filed_date":"2013-12-12","scope":"insider"},{"id":4530448,"accession":"0001140361-13-045902","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-13-045902","line_url":"/filing/0001140361-13-045902#line-1","is_derivative":false,"issuer_cik":"0001031927","issuer_name":"Echo Therapeutics, Inc.","issuer_ticker":"ECTE","issuer_name_source":null,"issuer_url":"/issuer/0001031927","owner_cik":null,"owner_name":"Platinum Liquid Opportunity Management (NY) LLC; Platinum Management (NY) LLC; Platinum Partners Liquid Opportunity Master Fund L.P.; Platinum Partners Value Arbitrage Fund, LP; Platinum Long Term Growth VII, LLC; LANDESMAN URI; Nordlicht Mark; Platinum-Montaur Life Sciences, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":13914.0,"shares_display":"13,914","price_per_share":2.75,"price_display":"2.75","price_state":"stated","total_value":38263.5,"total_display":"38,263.50","shares_owned_after":578452.0,"shares_owned_after_display":"578,452","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-12-10","filed_date":"2013-12-12","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001031927","name":"Echo Therapeutics, Inc.","url":"/issuer/0001031927","role":"Ten percent owner","n_filings":1,"first_seen":"2013-12-12","last_seen":"2013-12-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001413041","retrieved_at":"2026-08-21T20:56:57+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}